Author

Dafna Bar‐Sagi

New York UniversityORCID 0000-0003-2597-8948Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Akiko KoideiD· 1 shared Alfonso LopeziD· 1 shared Àlvaro Quintanal-VillalongaiD· 1 shared Andrew D. HauseriD· 1 shared Angeliki KaratzaiD· 1 shared Aristotelis TsirigosiD· 1 shared Chengwei PengiD· 1 shared Craig RamíreziD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akiko KoideORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 24, 2025

Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinoma

Angeliki Karatza, Maayan Pour, Jaylen M Powell…·Kwok‐Kin Wong

This study identifies genotype-specific immune and metabolic vulnerabilities in lung adenocarcinoma through cross-species analysis of human and mouse tumors.

DOI 10.1101/2025.08.24.671070

humanmouse

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 4, 2025

Exploiting macropinocytosis for therapeutic intervention in RAS mutant Multiple Myeloma

Nathan Beals, Craig Ramírez, Akiko Koide…·Dafna Bar‐Sagi

This paper develops a monobody-drug conjugate targeting mutant RAS in multiple myeloma, showing improved anti-tumor effects and safety in vitro and in vivo.

DOI 10.1101/2025.04.04.647098

humanproteomics

𝕏 PostBluesky